STIZADEL
LIVE

Serial Number

79435675

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Sep 12, 2025

Add to watchlist:

No watchlists yet
View on USPTO

STIZADEL Trademark

Serial Number: 79435675 • Registration: 8182465

STIZADEL is a trademark filed by Novartis AG on September 12, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

September 12, 2025

Registration Date

March 24, 2026

Published for Opposition

February 3, 2026

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 23, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 24, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Jan 29, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 14, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 13, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 6, 2026 CNSA
ASSIGNED TO EXAMINER
Dec 30, 2025 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 1, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 1, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 1, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 1, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 1, 2025 COAR
APPLICATION FILING RECEIPT MAILED
Nov 17, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 17, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 17, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 30, 2025 REPR